Showing results (1261-1270 of 10,440) with videos related to
Sort By:
Pageof 1,044
AIDS (London, England)|January 31, 2003
The long-term impact of HIV and orphanhood on the mortality and physical well-being of children in rural MalawiAmelia C Crampin, Sian Floyd, Judith R Glynn, et al.AIDS (London, England)|February 25, 2003
The effect of dual infection with HIV and malaria on pregnancy outcome in western KenyaJohn G Ayisi, Anna M van Eijk, Feiko O ter Kuile, et al.AIDS (London, England)|February 25, 2003
HIV increases the risk of malaria in women of all gravidities in Kisumu, KenyaAnna M van Eijk, John G Ayisi, Feiko O ter Kuile, et al.AIDS (London, England)|February 25, 2003
Determinants and prevalence of HIV infection in pregnant Peruvian womenJorge O Alarcon, Kay M Johnson, Barry Courtois, et al.AIDS (London, England)|February 25, 2003
Real-time quantitation of HIV-1 p24 and SIV p27 using fluorescence-linked antigen quantification assaysMatthew S Hayden, Emil H Palacios, Robert M GrantAIDS (London, England)|February 25, 2003
The impact on health-related quality of life of treatment interruptions in HIV-1-infected patientsHartmut B Krentz, M John GillAIDS (London, England)|January 25, 2002
Lymphocytes proliferate in blood and lymph nodes following interleukin-2 therapy in addition to highly active antiretroviral therapyUlrich R Hengge, Carsten Borchard, Stefan Esser, et al.AIDS (London, England)|January 25, 2002
Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infectionEric Delwart, Magdalena Magierowska, Maya Royz, et al.AIDS (London, England)|January 25, 2002
Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremiaSteven G Deeks, Jason D Barbour, Robert M Grant, et al.AIDS (London, England)|January 25, 2002
A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1Christine Armbruster, Gabriela M Stiegler, Brigitta A Vcelar, et al.Pageof 1,044